author-photo

Ilona Steigerwald

Grünenthal GmbH

42

Papers

1121

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations

2021 Pattern Recognition
Show All
- Source
- Cite
- Save
Citations (0)
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations.

2020 Pain
Show All
- Source
- Cite
- Save
Citations (16)
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-label, Phase 3b/4 Trial.

2016 Pain Practice
Show All
- Source
- Cite
- Save
Citations (44)
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study

2016 Pain Practice
Show All
- Source
- Cite
- Save
Citations (48)
Methodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release

2016 Pain Practice
Show All
- Source
- Cite
- Save
Citations (0)
Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

2015 Pain Practice
Show All
- Source
- Cite
- Save
Citations (49)
Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency.

2015 Journal of opioid management
Show All
- Source
- Cite
- Save
Citations (29)
Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain

2015 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (29)
Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open-label Continuation Arm of a Randomized Phase 3b Study

2015 Pain Practice
Show All
- Source
- Cite
- Save
Citations (25)
Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial

2014
Show All
- Source
- Cite
- Save
Citations (11)